---
reference_id: "PMID:40535343"
title: Immune checkpoint inhibitor-induced thyroiditis and its potential mechanisms.
authors:
- Mao X
- Mao C
- Liu J
- Wang X
- Mao Y
journal: Front Endocrinol (Lausanne)
year: '2025'
doi: 10.3389/fendo.2025.1584675
content_type: abstract_only
---

# Immune checkpoint inhibitor-induced thyroiditis and its potential mechanisms.
**Authors:** Mao X, Mao C, Liu J, Wang X, Mao Y
**Journal:** Front Endocrinol (Lausanne) (2025)
**DOI:** [10.3389/fendo.2025.1584675](https://doi.org/10.3389/fendo.2025.1584675)

## Content

1. Front Endocrinol (Lausanne). 2025 Jun 4;16:1584675. doi: 
10.3389/fendo.2025.1584675. eCollection 2025.

Immune checkpoint inhibitor-induced thyroiditis and its potential mechanisms.

Mao X(1), Mao C(1), Liu J(1), Wang X(1), Mao Y(2).

Author information:
(1)Department of Nuclear Medicine, The Affiliated Hospital of Jiangsu 
University, Zhenjiang, China.
(2)Department of Ultrasound Medicine, The Affiliated Hospital of Jiangsu 
University, Zhenjiang, China.

The expanding clinical utilization of immune checkpoint inhibitors (ICIs) in 
oncology has brought increasing attention to thyroid dysfunction as a prominent 
immune-related adverse event (irAE). Elucidating the pathophysiological 
mechanisms underlying ICI-induced thyroiditis represents a critical step toward 
developing evidence-based diagnostic protocols and targeted therapeutic 
interventions for cancer patients undergoing immunotherapy. This comprehensive 
review systematically examines current advances in understanding the 
etiopathogenesis of ICI-induced thyroiditis. First, we described pharmacological 
characterization of ICIs, then discussed multifactorial analysis of cellular and 
molecular contributors to thyroid autoimmunity following ICI administration and 
finally analyzed critical evaluation of emerging hypotheses regarding primary 
pathogenic drivers. Through this review, we aim to establish mechanistic 
connections between ICI pharmacodynamics and thyroid tissue immunopathology.

Copyright Â© 2025 Mao, Mao, Liu, Wang and Mao.

DOI: 10.3389/fendo.2025.1584675
PMCID: PMC12173899
PMID: 40535343 [Indexed for MEDLINE]

Conflict of interest statement: The authors declare that the research was 
conducted in the absence of any commercial or financial relationships that could 
be construed as a potential conflict of interest.